Further elucidation on “Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS–DES percutaneous coronary intervention: Method and …

KL Yew - International Journal of Cardiology, 2015 - internationaljournalofcardiology.com
It is heartening to note that there is viewership and interest in the article “Hybrid ABSORB
Bioresorbable vascular scaffold and drug eluting stent or hybrid BVS–DES percutaneous …

Letter regarding “Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS–DES percutaneous coronary intervention: Method and …

F Granata, E Moscarella… - International …, 2015 - internationaljournalofcardiology.com
With great interest, we read the article “Hybrid ABSORB bioresorbable vascular scaffold and
drug eluting stent or hybrid BVS–DES percutaneous coronary intervention: Method and …

Hybrid ABSORB bioresorbable vascular scaffold and drug eluting stent or hybrid BVS–DES percutaneous coronary intervention: method and rationale for hybrid …

KL Yew - International Journal of Cardiology, 2015 - internationaljournalofcardiology.com
A 46-year-old man with type II diabetes mellitus presented with inferior ST segment
elevation myocardial infarction to the emergency department. He was thrombolyzed …

Overlapping technique for hybrid percutaneous coronary intervention strategy utilising drug eluting stent and ABSORB bioresorbable vascular scaffold

KL Yew - International Journal of Cardiology, 2015 - internationaljournalofcardiology.com
A 58-year-old man presented with anterior myocardial infarction. He underwent primary
percutaneous coronary intervention (PCI) via the right radial artery approach. Coronary …

The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid …

RJ Gil, J Bil, T Pawłowski, N Yuldashev… - Kardiologia Polska …, 2016 - journals.viamedica.pl
Background: The number of percutaneous coronary interventions (PCI) with bioresorbable
vascular scaffolds (BVS) is increasing because these procedures offer additional benefits …

Bioresorbable coronary stent for the treatment of complex coronary lesions: Data from an all-comer registry

A Cuculo, A Ruggiero, A Centola, G Campanale… - International Journal of …, 2017 - Elsevier
Background The study aimed to report the results from an all-comers registry of patients
undergoing coronary angioplasty and treated with bioresorbable vascular scaffold (BVS) …

Everolimus-eluting bioresorbable coronary scaffold in Asian patients: A 2-year follow-up.

S Azad, U Gul, A Javed - JPMA. The Journal of the Pakistan Medical …, 2020 - europepmc.org
Indo-Pakistan population has one of the highest risk of coronary artery disease (CAD) in the
world. Percutaneous interventions with the use of stents has been the mainstay of treatment …

Hybrid percutaneous coronary intervention with bioresorbable vascular scaffolds in combination with drug-eluting stents or drug-coated balloons for complex coronary …

A Tanaka, RJ Jabbour, S Mitomo, A Latib… - JACC: Cardiovascular …, 2017 - jacc.org
Bioresorbable vascular scaffolds (BVS) have become an attractive option in the
percutaneous coronary intervention field due to the potential advantages associated with the …

A hybrid strategy with bioresorbable vascular scaffolds and drug eluting stents for treating complex coronary lesions

RJ Jabbour, A Ielasi, A Tanaka, M Leoncini… - Cardiovascular …, 2017 - Elsevier
Background Due to the inherent limitations of current generation BVSs, complex coronary
artery disease often contains BVS unsuitable segments. Our aim was to assess the …

Novel use of absorb bioresorbable vascular scaffold and STENTYS self-apposing coronary stent for complex saphenous vein grafts intervention

KL Yew - International journal of cardiology, 2014 - internationaljournalofcardiology.com
A 53-year-old man suffered an episode of severe chest pain while he was working at an
overseas project. After the chest pain had subsided, he flew back to his home country and …